<http://schema.org/description>
"Sanofi and Regeneron Pharmaceuticals said their Zaltrap drug candidate failed to meet targets in a late-stage study for the treatment of prostate cancer, though U.S. authorities were reviewing it for use in treating colon cancer."^^<http://www.w3.org/2001/XMLSchema#string>
<http://in.reuters.com/article/us-sanofi-regeneron-idINBRE83406G20120405>